secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0000310764-23-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q4 organic sales +13.2%, adj. EPS $3.00; FY23 adj. EPS guide $9.85-10.15
--------------------------------------------------------------------------------

- Q4 reported sales $5.2B (+10.7% YoY); organic sales +13.2% driven by MedSurg and Neurotechnology (+16.9% organic).
- Q4 reported EPS $1.47 (-15.0%); adjusted EPS $3.00 (+10.7%) – includes $216M goodwill impairment in Spine.
- Full-year sales $18.4B (+7.8% reported); organic sales +9.7%; adjusted EPS $9.34 (+2.8%).
- 2023 outlook: organic sales growth 7.0-8.5%; adjusted EPS $9.85-$10.15.
- Adjusted operating margin contracted 70 bps in Q4 to 26.6% and 180 bps for FY to 23.8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/0000310764-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076423000005/syk-20230131.htm
  HTML page:      https://secwatch.observer/filing/0000310764-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer